The closing price of Nuvalent Inc (NASDAQ: NUVL) was $64.75 for the day, down -0.81% from the previous closing price of $65.28. On the day, 770835 shares were traded.
Ratios:
Our analysis of NUVL’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 22.83 and its Current Ratio is at 22.83. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Leerink Partners on April 01, 2024, Upgraded its rating to Outperform and sets its target price to $110 from $69 previously.
On February 23, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $105.Robert W. Baird initiated its Outperform rating on February 23, 2024, with a $105 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Apr 08 ’24 when Shair Matthew sold 37,500 shares for $68.44 per share. The transaction valued at 2,566,479 led to the insider holds 1,612,198 shares of the business.
Miller Deborah Ann sold 3,000 shares of NUVL for $220,787 on Apr 04 ’24. The Chief Legal Officer now owns 33,300 shares after completing the transaction at $73.60 per share. On Apr 01 ’24, another insider, Shair Matthew, who serves as the Director of the company, sold 37,500 shares for $76.92 each. As a result, the insider received 2,884,337 and left with 1,649,698 shares of the company.
Stock Price History:
Over the past 52 weeks, NUVL has reached a high of $89.39, while it has fallen to a 52-week low of $28.67.
Shares Statistics:
A total of 58.63M shares are outstanding, with a floating share count of 32.64M. Insiders hold about 49.06% of the company’s shares, while institutions hold 61.15% stake in the company.
Earnings Estimates
The firm’s stock currently is rated by Nuvalent, Inc. analysts.
EPS for the following year is $Stocks, with Stocks analysts recommending between $Index and $Stocks.
